American Embryo Transfer Association (AETA)

Time 2020-10-14 18:03:22

Web Name: American Embryo Transfer Association (AETA)

WebSite: http://www.aeta.org

ID:82083

Keywords:

Embryo,American,Transfer,

Description:

2020 AETA-CETA/ACTE JOINT ANNUAL CONVENTION We would like to thank you for your participation in the 2020 AETA and CETA/ACTE Joint Annual Virtual Convention. Although we all would have preferred to visit and participate in person this fall in Madison, Wisconsin, we feel that this conference highlighted the perseverance and flexibility typical of our profession. The convention committee succeeded in making the best of the circumstances. We hope you gained some benefit from the program that was presented. We remind you to provide your feedback so that we can deliver the content and experience that you are looking for in the future to the best of our abilities. Thank you, Matthew Dorshorst, AETA president Luc Besner, CETA/ACTE president Congratulations to the 2019 AETA Student Scholarship Winners! Josh Brown, University of Minnesota David Hardesty, University of Wisconsin-Madison Sarah Harp, The Ohio State University Makayla Hawbaker, University of Wisconsin Russell Johnson, Tuskegee University Kaitlin Karl, Michigan State University Mariah Markle, Louisiana State University Hilary Seals, Auburn University Nicholas Shen, Lincoln Memorial University Michael Topper, University of Pennsylvania Also pictured: President Matt Iager and Vice President Matt Dorshorst The AABP office has received questions from members regarding the legality of using compounded estradiol products in cattle for embryo transfer protocols. AABP has also been in discussion with the FDA about the use of compounded estradiol products in food animals. Compounding from approved drugs in animals is only permitted under the narrowly defined conditions outlined in AMDUCA (Section 21 CFR 530.13). To be permitted, extralabel use from compounding of approved animal drugs or approved human drugs must be in compliance with all relevant provisions of 21 CFR 530 (AMDUCA), including the provisions limiting extralabel use to treatment modalities when the health of an animal is threatened or suffering or death may result from failure to treat. The extralabel use regulation also does not provide for compounding from active pharmaceutical ingredients (API or bulk drugs, i.e., the raw chemical) for use in animals. Therefore, it is illegal for veterinarians to use or prescribe compounded estradiol for cattle or any form of estrogenic compounds for production purposes including embryo transfer and synchronization protocols. AABP encourages cattle veterinarians to refrain from administering or prescribing compounded estradiol for the following reasons: AMDUCA only allows for extralabel drug use when the health of an animal is threatened. There is no production allowance, particularly for compounding; therefore, one cannot use human-approved drugs (i.e., ECP, Pfizer) or a different form of an animal-approved drug (i.e., growth-promoting implants) for production purposes. Compounding from a bulk product is specifically prohibited in the AMDUCA regulations. The safety, potency, efficacy, stability, sterility, and disposition of compounded products is unknown. Compounded products do not undergo FDA inspection, potency testing, or efficacy testing. Veterinary compounding pharmacies that also compound for humans are under federal regulation and FDA inspected; however, this only applies to the human side of the compounding operation. Veterinary compounding pharmacies do not have this level of oversight. There is no guarantee of the safety or efficacy of compounded products and the liability for the use of such products falls on the veterinarian in the event of an adverse reaction or violative residue. Because the safety, efficacy, potency, and disposition of the compounded product is not known, it is impossible to assign a withdrawal interval for compounded products. The use of compounded products in food animals places a veterinarian at a risk of professional liability. The need for estradiol for successful embryo transfer protocols has not been unequivocally established. For example, data from nearly 7,000 collections did not demonstrate a difference when using GnRH in place of estradiol in the protocol. Additional references are available on the Reproduction Committee page of the website. Veterinarians who engage in federally prohibited activities put themselves at risk and also risk the profession s reputation for appropriate and judicious oversight of pharmaceutical products in our cattle patients. This is especially of concern when using an unapproved and illegally manufactured hormone product. AABP Newsletter 5 May 2019 Please contact the Fred Gingrich at fred@aabp.org with any questions. Global Genetic Improvement Through Embryo Technology Your browser does not support the HTML5 video tag. American Embryo Transfer Association 1800 South Oak St. Suite 100 Champaign IL 61820-6974 Phone (217)398-2217 Fax (217)398-4119 Email: aeta@assochq.orgUnified Login for User AccountsAETA has implemented the Unified Login technology to relieve members of having to remember multiple login/password combinations. Wherever you see this icon, you are able to use the same login information!

TAGS:Embryo American Transfer 

<<< Thank you for your visit >>>

Hot Websites